BO
TEVA icon

Bank OZK’s Teva Pharmaceuticals TEVA Stock Holding History

Bank OZK’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,598
Closed -$221K – 143
2017
Q3 		$221K Sell
12,598
-2,030
-14% -$45.7K 0.09% 119
2017
Q2 		$486K Sell
14,628
-4,531
-24% -$140K 0.17% 93
2017
Q1 		$614K Sell
19,159
-1,635
-8% -$55.8K 0.2% 80
2016
Q4 		$754K Sell
20,794
-3,155
-13% -$126K 0.25% 62
2016
Q3 		$1.1M Sell
23,949
-76
-0.3% -$3.96K 0.4% 43
2016
Q2 		$1.21M Buy
24,025
+5,740
+31% +$306K 0.44% 38
2016
Q1 		$979K Buy
18,285
+165
+0.9% +$9.68K 0.36% 43
2015
Q4 		$1.19M Buy
18,120
+160
+0.9% +$9.89K 0.42% 34
2015
Q3 		$1.01M Buy
17,960
+985
+6% +$63.9K 0.39% 36
2015
Q2 		$1M Buy
16,975
+65
+0.4% +$4.01K 0.35% 40
2015
Q1 		$1.05M Buy
16,910
+1,585
+10% +$92.2K 0.38% 36
2014
Q4 		$881K Buy
15,325
+1,200
+8% +$66.9K 0.3% 45
2014
Q3 		$759K Buy
14,125
+1,715
+14% +$90.9K 0.28% 48
2014
Q2 		$650K Buy
12,410
+1,895
+18% +$96.9K 0.23% 60
2014
Q1 		$555K Buy
10,515
+2,150
+26% +$99.4K 0.2% 63
2013
Q4 		$335K Buy
8,365
+1,160
+16% +$45.7K 0.13% 87
2013
Q3 		$272K Buy
7,205
+50
+0.7% +$1.95K 0.12% 89
2013
Q2 		$280K Buy
+7,155
New +$279K 0.21% 41

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Bank OZK's TEVA Position: Q4 2017 in Review

Bank OZK sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 12,598 shares — an estimated $221K sold.

Bank OZK first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $1.21M in Q2 2016. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Bank OZK reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Bank OZK sold 12,598 Teva Pharmaceuticals shares in Q4 2017, an estimated $221K.
  • Bank OZK first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Bank OZK's Teva Pharmaceuticals position peaked at $1.21M in Q2 2016.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Bank OZK's 13F filing for Q4 2017, filed 5 Feb 2018.